The Effect of Mitomycin C on the number of Keratocytes on the Posterior Wall of the Stroma of Cornea after Photorefractive Keratectomy

Authors

  • Hanieh Ahmadi
  • Majid Reza Sheikh Rezaei
  • Mohammad Naeim AminiFard
  • Hamed Jafarpour

Abstract

Introduction: We have decided to investigate its effect on a number of keratocytes on the posterior wall of the stroma of cornea, in which stromal removal depth has little effect on.

Methods: This is a cohort clinical trial. All patients with the required criteria for entering the study after filling the consent, they were first examined by the Confoscan III system and then the number of keratocytes on the posterior wall of the stroma of cornea was measured. At the end of the treatment, patients were followed up (end of month 3) with posterior keratocytes cells’ count.

Results: In this study, out of 13 patients (26 eyes) referring to the clinic, 8 (51.5%) were male and 5 (38.5%) were female. The mean refractive index before surgery was -3.6 ± 0.8 diopters. Also, the mean number of keratocytes on the posterior wall of the stroma of cornea after surgery was 714.7 ± 12.9, with the lowest of 697.5 and the highest of 726.3. There was no statistically significant difference between the number of keratocytes before and after surgery (P = 0.838).

Conclusion: The use of 0.02% mitomycin, topically, during keratorefractive surgery does not affect the number of keratocytes on the posterior wall of the stroma of cornea.

References

Rajan MS, Jaycock P, O'Brart D, Nystrom HH, Marshall J. A long-term study of photorefractive keratectomy: 12-year follow-up. Ophthalmology. 2004;111(10):1813-24.

Mohan RR, Hutcheon AE, Choi R, Hong J, Lee J, Mohan RR, et al. Apoptosis, necrosis, proliferation, and myofibroblast generation in the stroma following LASIK and PRK. Experimental eye research. 2003;76(1):71-87.

Carones F, Vigo L, Scandola E, Vacchini L. Evaluation of the prophylactic use of mitomycin-C to inhibit haze formation after photorefractive keratectomy. Journal of Cataract & Refractive Surgery. 2002;28(12):2088-95.

Pak JH, Lee SY, Tchah H. Mitomycin C-induced reduction of keratocytes and fibroblasts after photorefractive keratectomy. Investigative ophthalmology & visual science. 2004;45(9):2978-84.

Majmudar PA, Forstot SL, Dennis RF, Nirankari VS, Damiano RE, Brenart R, et al. Topical mitomycin-C for subepithelial fibrosis after refractive corneal surgery. Ophthalmology. 2000;107(1):89-94.

Rubinfeld RS, Pfister RR, Stein RM, Foster CS, Martin NF, Stoleru S, et al. Serious complications of topical mitomycin-C after pterygium surgery. Ophthalmology. 1992;99(11):1647-54.

Dougherty PJ, Hardten DR, Lindstrom RL. Corneoscleral melt after pterygium surgery using a single intraoperative application of mitomycin-C. Cornea. 1996;15(5):537-40.

Talamo JH, Gollamudi S, Green WR, De La Cruz Z, Filatov V, Stark WJ. Modulation of corneal wound healing after excimer laser keratomileusis using topical mitomycin C and steroids. Archives of Ophthalmology. 1991;109(8):1141-6.

Goldsberry DH, Epstein RJ, Majmudar PA, Epstein RH, Dennis RF, Holley G, et al. Effect of mitomycin C on the corneal endothelium when used for corneal subepithelial haze prophylaxis following photorefractive keratectomy. Journal of Refractive Surgery. 2007;23(7):724-7.

Lai Y-H, Wang H-Z, Lin C-P, Chang S-J. Mitomycin C alters corneal stromal wound healing and corneal haze in rabbits after argon-fluoride excimer laser photorefractive keratectomy. Journal of ocular pharmacology and therapeutics. 2004;20(2):129-38.

Azar DT, Jain S. Topical MMC for subepithelial fibrosis after refractive corneal surgery. Ophthalmology. 2001;108(2):239-40.

Wilson SE, Mohan RR, Hong J-W, Lee J-S, Choi R, Mohan RR. The wound healing response after laser in situ keratomileusis and photorefractive keratectomy: elusive control of biological variability and effect on custom laser vision correction. Archives of Ophthalmology. 2001;119(6):889-96.

Midena E, Gambato C, Miotto S, Cortese M, Salvi R, Ghirlando A. Long-term effects on corneal keratocytes of mitomycin C during photorefractive keratectomy: a randomized contralateral eye confocal microscopy study. Journal of Refractive Surgery. 2007;23(9):S1011-S4.

Katbab A, Dabiri F, Eghtedari M, Attarzadeh A. Histopathologic Changes Induced by Topical Mitomycin-C in Rabbit Corneas. 2007.

Lee JS, Oum BS, Lee SH. Mitomycin C influence on inhibition of cellular proliferation and subsequent synthesis of type I collagen and laminin in primary and recurrent pterygia. Ophthalmic research. 2001;33(3):140-6.

Netto MV, Mohan RR, Sinha S, Sharma A, Gupta PC, Wilson SE. Effect of prophylactic and therapeutic mitomycin C on corneal apoptosis, cellular proliferation, haze, and long-term keratocyte density in rabbits. Journal of refractive surgery. 2006;22(6):562-74.

Tchah H, Lee S-a, Sung K, Cho BJ, Kook MS. Apoptosis in keratocytes caused by mitomycin C. Investigative ophthalmology & visual science. 2003;44(5):1912-7.

Downloads

Published

21.12.2019

Issue

Section

Original Research

Most read articles by the same author(s)